Chemical Structure : CD161
货号: PC-61129Not For Human Use, Lab Use Only.
CD161 (NKR-P1A) is a potent, selective, orally bioavailable BET bromodomain inhibitor with IC50 of 7.2 and 28.2 nM for BRD4 BD2 and BRD4 BD1, respectively.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CD161 (NKR-P1A) is a potent, selective, orally bioavailable BET bromodomain inhibitor with IC50 of 7.2 and 28.2 nM for BRD4 BD2 and BRD4 BD1, respectively.
CD161 shows high affinity for BRD2, BRD3, BRD4 and BRDT bromodomains, and liitle to no affintiy for other bromodomains (Ki>500 nM).
CD161 exhibits cytotoxicity against a panel of breast cancer cell lines (MDA-MB-231 IC50=244 nM).
CD161 demonstrates significant antitumor activity in the MV4;11 leukemia and MDA-MB-231 triple-negative breast cancer xenograft models in mice, has excellent microsomal stability and good oral pharmacokinetics in rats and mice.
分子量 | 435.487 | |
分子式 | C26H21N5O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Zhao Y, et al. J Med Chem. 2017 May 11;60(9):3887-3901.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright